Abstract
This cross-sectional study analyzes beneficiary cost-sharing payments among Medicare Advantage prescription drug plan and stand-alone Part D plan beneficiaries who reached the out-of-pocket cap in 2025.
Alexandra G. Hames, Jon Rosen, Insiya B. Poonawalla
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cost-related medication nonadherence after the Inflation Reduction Act.
10.1001/jamainternmed.2026.0012 · 2026
Medicare Part D redesign savings may be lower for beneficiaries with spending below the out-of-pocket cap.
10.1377/hlthaff.2024.01527 · 2025
Inflation Reduction Act changes to Part D plan design: lower premiums, higher deductibles, and some smaller formularies.
10.1377/hlthaff.2025.00644 · 2026
Changes in Medicare Part D plan designs after the Inflation Reduction Act.
10.1001/jamainternmed.2025.4003 · 2025
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
datacite
Confidence 0%
Changes in Medicare Part D plan designs after the Inflation Reduction Act.
10.1001/jamainternmed.2025.4003 · doi-reference
Inflation Reduction Act changes to Part D plan design: lower premiums, higher deductibles, and some smaller formularies.
10.1377/hlthaff.2025.00644 · doi-reference
Medicare Part D redesign savings may be lower for beneficiaries with spending below the out-of-pocket cap.
10.1377/hlthaff.2024.01527 · doi-reference
Cost-related medication nonadherence after the Inflation Reduction Act.
10.1001/jamainternmed.2026.0012 · doi-reference